Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation

Autor: Geraint Fuller, Maggie M. K. Wong, Jane Vowles, Lauren M Watson, Andrea H. Németh, Kevin Talbot, Esther B. E. Becker, Stephanie D. Hoekstra, Sally A. Cowley, Olaf Ansorge
Rok vydání: 2018
Předmět:
0301 basic medicine
Adult
Male
Cerebellum
Ataxia
Induced Pluripotent Stem Cells
Stem cells
Protein kinase C gamma
Biology
Models
Biological

Protein Aggregation
Pathological

lcsh:RC346-429
Pathology and Forensic Medicine
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Catalytic Domain
medicine
Humans
Spinocerebellar Ataxias
Neurodegeneration
Kinase activity
Induced pluripotent stem cell
lcsh:Neurology. Diseases of the nervous system
Protein Kinase C
C1 domain
Aged
Middle Aged
medicine.disease
PRKCG Gene
3. Good health
Cell biology
Protein Transport
030104 developmental biology
medicine.anatomical_structure
Purkinje cells
Mutation
Nerve Degeneration
Spinocerebellar ataxia
Female
Neurology (clinical)
Autopsy
medicine.symptom
Protein Kinases
030217 neurology & neurosurgery
Zdroj: Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-14 (2018)
Acta Neuropathologica Communications
ISSN: 2051-5960
Popis: Spinocerebellar ataxia type 14 (SCA14) is a subtype of the autosomal dominant cerebellar ataxias that is characterized by slowly progressive cerebellar dysfunction and neurodegeneration. SCA14 is caused by mutations in the PRKCG gene, encoding protein kinase C gamma (PKCγ). Despite the identification of 40 distinct disease-causing mutations in PRKCG, the pathological mechanisms underlying SCA14 remain poorly understood. Here we report the molecular neuropathology of SCA14 in post-mortem cerebellum and in human patient-derived induced pluripotent stem cells (iPSCs) carrying two distinct SCA14 mutations in the C1 domain of PKCγ, H36R and H101Q. We show that endogenous expression of these mutations results in the cytoplasmic mislocalization and aggregation of PKCγ in both patient iPSCs and cerebellum. PKCγ aggregates were not efficiently targeted for degradation. Moreover, mutant PKCγ was found to be hyper-activated, resulting in increased substrate phosphorylation. Together, our findings demonstrate that a combination of both, loss-of-function and gain-of-function mechanisms are likely to underlie the pathogenesis of SCA14, caused by mutations in the C1 domain of PKCγ. Importantly, SCA14 patient iPSCs were found to accurately recapitulate pathological features observed in post-mortem SCA14 cerebellum, underscoring their potential as relevant disease models and their promise as future drug discovery tools.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje